CN209416919U - Cellanalyzer - Google Patents
Cellanalyzer Download PDFInfo
- Publication number
- CN209416919U CN209416919U CN201821622446.8U CN201821622446U CN209416919U CN 209416919 U CN209416919 U CN 209416919U CN 201821622446 U CN201821622446 U CN 201821622446U CN 209416919 U CN209416919 U CN 209416919U
- Authority
- CN
- China
- Prior art keywords
- blood
- measured
- blood sample
- reagent
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
This application discloses a kind of cellanalyzer, which includes: blood sampling unit, for acquiring and providing blood sample to be measured；Reagent provides device, analyzes reagent used in blood sample to be measured for providing；Blood sample reaction unit provides reagent provided by device for receiving blood sample and reagent to be measured provided by blood sampling unit, to respectively obtain the blood sample to be measured after blood sample and the H anti-binding to be measured after the blood sample to be measured after A anti-binding, B anti-binding；Blood examination device, including fluorescent optics detection system, the fluorescent optics detection system carries out Blood grouping for the blood sample to be measured after receiving A anti-binding respectively, the blood sample to be measured after blood sample and the H anti-binding to be measured after B anti-binding, to show that A type blood testing result, Type B blood testing result, O-shaped blood examination are surveyed as a result, obtaining the Blood grouping result of blood sample to be measured in turn respectively.Blood group is detected by the above-mentioned means, the application cellanalyzer more comprehensive, accurate can obtain.
Description
Technical field
This application involves blood cell analysis technical fields, more particularly to a kind of cellanalyzer.
Background technique
Currently, when carrying out blood group and blood routine detects, blood group is usually completed by an independent blood type analytical instrument
Detection, and detected by the cellanalyzer of another individual three classification or five classification.
In these cases, it needs to separate and be detected twice, working efficiency is low；And it is taken out twice with same patient
Sample increases patient suffering.
Utility model content
The application mainly solving the technical problems that provide a kind of cellanalyzer, can be more comprehensive, accurate pair
Blood group is detected.
In order to solve the above technical problems, the technical solution that the application uses is: providing a kind of cellanalyzer, institute
Stating cellanalyzer includes: blood sampling unit, for acquiring and providing blood sample to be measured；Reagent provides device, for providing
Analyze reagent used in the blood sample to be measured；Blood sample reaction unit, for receiving institute provided by the blood sampling unit
It states blood sample to be measured and the reagent provides the reagent provided by device, to respectively obtain the blood to be measured after A anti-binding
The blood sample to be measured after blood sample and H anti-binding to be measured after sample, B anti-binding；Blood examination device, the blood examination device include
Fluorescent optics detection system, the fluorescent optics detection system are used to receive the blood sample to be measured after the A anti-binding, described respectively
The blood sample to be measured after blood sample to be measured and the H anti-binding after B anti-binding carries out Blood grouping, to show that A type blood examination is surveyed respectively
As a result, Type B blood testing result, O-shaped blood examination are surveyed as a result, obtaining the Blood grouping result of the blood sample to be measured in turn.
The beneficial effect of the application is: being in contrast to the prior art, the application cellanalyzer can utilize glimmering
Light Systems for optical inspection carries out Blood grouping to blood sample to be measured, obtains A type blood testing result, the Type B blood examination of blood sample to be measured respectively
It surveys result and O-shaped blood examination is surveyed as a result, simultaneously obtaining the blood group of blood sample to be measured in turn, obtained Blood grouping result is comprehensively, accurately
And high reliablity.
Detailed description of the invention
In order to more clearly explain the technical solutions in the embodiments of the present application, make required in being described below to embodiment
Attached drawing is briefly described, it should be apparent that, the drawings in the following description are only some examples of the present application, for
For those of ordinary skill in the art, without creative efforts, it can also be obtained according to these attached drawings other
Attached drawing.Wherein:
Fig. 1 is the structural schematic diagram of one embodiment of the application cellanalyzer；
Fig. 2 is the structural schematic diagram of another embodiment of the application cellanalyzer；
Fig. 3 is the structural schematic diagram of the another embodiment of the application cellanalyzer；
Fig. 4 is the structural schematic diagram of fluorescent optics detection system in the application cellanalyzer embodiment.
Specific embodiment
Below in conjunction with the attached drawing in the embodiment of the present application, technical solutions in the embodiments of the present application carries out clear, complete
Site preparation description, it is clear that described embodiments are only a part of embodiments of the present application, rather than whole embodiments.Based on this
Embodiment in application, those of ordinary skill in the art are obtained every other under the premise of not making creative labor
Embodiment shall fall in the protection scope of this application.
Referring to Fig. 1, Fig. 1 is the structural schematic diagram of one embodiment of the application cellanalyzer, the blood cell analysis
Instrument includes: blood sampling unit 10, reagent offer device 20, blood sample reaction unit 30 and blood examination device 40.
Wherein, blood sampling unit 10 is for acquiring and providing blood sample to be measured.Specifically, before carrying out blood examination,
The blood sample of patient's privileged site can be acquired by heparin tube, and the rack for test tube for placing collection tube is further placed on this embodiment party
In cellanalyzer in formula, when carrying out blood examination, blood sampling unit 10 can further acquire in heparin tube to
Blood sample is surveyed, and in turn under the control of certain means, blood sample to be measured collected is provided to blood sample reaction unit 30.
Reagent provides device 20 and analyzes reagent used in blood sample to be measured for providing.It should be pointed out that usually carrying out
Blood sample used by blood examination is not directly to be detected using the blood that is extracted from patient's body, and need according to being wanted
The test item of progress is pocessed blood sample to be measured collected by certain means, such as dilution, incubation, dissolution,
Then it reuses.Device 20 further then is provided using reagent in present embodiment, certain reagent is provided, and be transported to
Blood sample reaction unit 30, to handle blood sample to be measured.
Blood sample reaction unit 30 is for receiving blood sample and reagent offer device to be measured provided by blood sampling unit 10
Reagent provided by 20, and mixed, reacted, the blood sample to be measured after being reacted.As described above, passing through in present embodiment
Reagent provided by device 20 is provided using reagent and blood sample to be measured carries out physics and/chemical reaction, to can be used in
The blood sample to be measured of detection.
Blood examination device 40 is used to receive the blood sample to be measured after reaction, and carries out haemocyte to the blood sample to be measured after reaction
Analysis and Blood grouping, to obtain the blood routine parameter and Blood grouping result of blood sample to be measured.
It should be pointed out that the blood examination device 40 in present embodiment can carry out reaction treatment to blood sample to be measured
After blood routine detection and Blood grouping are carried out while realize in same equipment, to obtain blood routine parameter and blood group inspection
It surveys as a result, without being detected respectively, to improve working efficiency；Simultaneously as need to only acquire a blood sample, therefore, also
Patient suffering can be reduced.
Wherein, blood sampling unit 10 provide blood sample to be measured to blood sample reaction unit 30, reagent provides device 20 to blood
When the offer reagent of sample reaction unit 30 and blood sample reaction unit 30 provide blood sample to be measured to blood examination device 40, Ke Yitong
Multiple means realization is crossed, such as blood sampling unit 10 or reagent can be provided to the driving of device 20 to corresponding position and gone forward side by side
And by blood sample to be measured, perhaps reagent release can also be realized in corresponding blood sample reaction unit 30 or using other modes.
In one embodiment, incorporated by reference to Fig. 2 and Fig. 3, cellanalyzer further includes distribution system 50.Wherein, it distributes
System 50 is used to provide blood sample to be measured, the reagent in blood sampling unit 10 to the reagent in device 20 that be respectively allocated to blood sample anti-
Device 30 is answered, and the blood sample to be measured after reacting in blood sample reaction unit 30 is distributed to blood examination device 40.
Specifically, distribution system 50 can be a kind of " sucking-release " device, such as need to provide reagent into device 20
In reagent when distributing to blood sample reaction unit 30, the one end that can pass through distribution system 50 provides in device 20 from reagent " inhales
Enter " a certain amount of reagent, and further worked as reagent " release " to blood sample reaction unit 30 by the other end of distribution system 50
In." sucking-release " of distribution system 50 can be by the way that syringe be arranged in distribution system 50 or quantifies in present embodiment
Pump etc. is realized.
In aforesaid way, by using distribution system 50, blood sampling unit 10, reagent can be provided device 20 and
Liquid in blood sample reaction unit 30 is automatically provided to corresponding device, handles manually without operator, to improve
The working efficiency of haemocyte detection.
Further referring to Fig. 2, in one embodiment, blood sample reaction unit 30 includes leukocyte differential count reaction tank 31, A
The anti-reaction tank 33 of anti-reaction tank 32, B and the anti-reaction tank 34 of H, blood examination device 40 include leukocyte differential count/Blood grouping system
41。
Wherein, leukocyte differential count reaction tank 31 is used to form the blood sample to be measured for carrying out leukocyte differential count detection, and A anti-reflective is answered
Pond 32, the anti-reaction tank 33 of B and the anti-reaction tank 34 of H are then used to form the blood sample to be measured for carrying out Blood grouping.Specifically, A anti-reflective is answered
The association reaction that pond 32 resists for blood sample to be measured and A, the association reaction that the anti-reaction tank 33 of B resists for blood sample to be measured and B, H anti-reflective
Answer pond 34 for the association reaction that blood sample to be measured and H resist, in present embodiment, need each blood sample to be measured of comprehensive analysis with it is corresponding
The combination degree that A is anti-, B is anti-, H is anti-, and then obtain Blood grouping result.
Specifically, the blood sample and reagent to be measured in blood sampling unit 10 can be provided in device 20 by distribution system 50
Reagent distribute into leukocyte differential count reaction tank 31, the anti-reaction tank 32 of A, the anti-reaction tank 33 of B and the anti-reaction tank 34 of H, to obtain
The blood sample to be measured after blood sample to be measured, B anti-binding, the blood to be measured after H anti-binding after leukocyte differential count blood sample to be measured, A anti-binding
Sample.
Further, it includes that dilution provides unit 21, leukocyte classification hemolytic agent provides unit that reagent, which provides device 20,
22, the anti-reagent of A provides the anti-reagent offer unit 24 of unit 23, B, the anti-reagent of H provides unit 25.Wherein, dilution provides unit
21 for providing dilution, and leukocyte classification hemolytic agent provides unit 22 for providing leukocyte classification hemolytic agent, and the anti-reagent of A mentions
For unit 23 for providing the anti-reagent of A, B anti-reagent unit 24 is provided, unit 25 is provided and is used for providing the anti-reagent of B, H anti-reagent
In the offer anti-reagent of H.
Wherein, A is anti-, B is anti-, anti-refer respectively to can be with the Staphylococal Protein A of erythrocyte surface, B antigen and H antigen binding in blood by H
Antibody.In present embodiment, the knot that A is anti-, B is anti-, H is anti-is carried out respectively in the anti-reaction tank of A, the anti-reaction tank of B, the anti-reaction tank of H
Reaction is closed, the expression that can successively assess tri- antigens of A, B, H by leukocyte differential count/Blood grouping system 41 after the reaction was completed is strong
Degree, it is different by the expression intensity of three antigen, it can be deduced that the blood group of blood sample to be measured.
More specifically, distribution system 50 can according to specific detection project to blood sample to be measured and reagent etc. to dividing
Match.For example, distribution system 50, which first can provide dilution to the dilution in unit 21, is respectively allocated to leukocyte differential count reaction tank
31, the anti-reaction tank 32 of A, the anti-reaction tank 33 of B and the anti-reaction tank 34 of H, then again by the blood sample to be measured in blood sampling unit 10 point
Fen Pei not be in above-mentioned each reaction tank, and then leukocyte classification hemolytic agent is provided to the leukocyte differential count haemolysis in unit 22 again
Agent, the anti-reagent of A provide the anti-reagent of the anti-reagent of B, H that the anti-reagent of the anti-reagent of A, B in unit 23 is provided in unit 24 and provide unit
The anti-reagent of H in 25 respectively corresponds distribution to leukocyte differential count reaction tank 31, the anti-reaction tank 32 of A, the anti-reaction tank 33 of B and H anti-reflective
Pond 34 is answered, is obtained so that each blood sample to be measured reacts in each reaction tank.
After obtaining each blood sample to be measured, it can further pass through distribution system 50 for obtained leukocyte differential count blood to be measured
Leucocyte is sent into the blood sample to be measured after blood sample to be measured, B anti-binding after sample, A anti-binding, the blood sample timesharing to be measured after H anti-binding
Classification/Blood grouping system 41 is detected, to obtain leukocyte differential count testing result and Blood grouping result.
It is readily appreciated that ground, four kinds of blood samples to be measured in present embodiment are in leukocyte differential count/Blood grouping system 41
In detected, it is therefore desirable to timesharing carry out, the sequence specifically detected is without limitation.
Further referring to Fig. 3, in another embodiment, blood sample reaction unit 30 includes leukocyte differential count/blood group inspection
Survey reaction tank 35, wherein leukocyte differential count/35 time-sharing multiplex of Blood grouping reaction tank, by distribution system 50 by blood specimen collection
The reagent that blood sample and reagent to be measured in device 10 are provided in device 20 is distributed to leukocyte differential count/Blood grouping reaction tank 35,
Blood sample to be measured, the blood sample to be measured after B anti-binding, H anti-binding after obtaining leukocyte differential count blood sample to be measured, A anti-binding with timesharing
Blood sample to be measured afterwards, and further pass through distribution system 50 for blood sample to be measured, the B after leukocyte differential count blood sample to be measured, A anti-binding
Blood sample timesharing to be measured after blood sample to be measured, H anti-binding after anti-binding is sent into leukocyte differential count/Blood grouping system 41 and is examined
It surveys, to obtain leukocyte differential count testing result and Blood grouping result.
Specifically, distribution system 50 first dilution is provided dilution in unit 21, in blood sampling unit 10 to
The leucocyte hemolytic agent surveyed in blood sample and leukocyte classification hemolytic agent offer unit 22 is sequentially allocated to leukocyte differential count/blood group
Reaction tank 35 is detected, to obtain leukocyte differential count blood sample to be measured, and then obtained leukocyte differential count blood sample feeding to be measured is white
Cell classification/Blood grouping system 41, is detected；Then successively dilution is provided in unit 21 by distribution system 50 again
Dilution, the anti-reagent of blood sample and A to be measured in blood sampling unit 10 provides the anti-reagent of A in unit 23 and distributes to white thin
Born of the same parents' classification/Blood grouping reaction tank 35 so that hybrid reaction obtains the blood sample to be measured after A anti-binding, and in turn resists obtained A
Blood sample to be measured in conjunction with after is sent into leukocyte differential count/Blood grouping system 41, is detected；Then after being successively B anti-binding
The acquisition and detection of blood sample to be measured after the acquisition of blood sample to be measured and detection and H anti-binding, specifically with after A anti-binding to
Acquisition and the testing process for surveying blood sample are identical, and details are not described herein again.It is pointed out that above-mentioned leukocyte differential count blood to be measured
The blood sample to be measured after blood sample and the H anti-binding to be measured after blood sample to be measured, B anti-binding after sample, A anti-binding is sent into white at times
Cell classification/Blood grouping system 41, sequence in no particular order, it is above only as an example.
Further referring to Fig. 4, in an application scenarios, above-mentioned leukocyte differential count/Blood grouping system 41 is fluorescence
Systems for optical inspection 411.Leukocyte differential count detection and Blood grouping carry out in the fluorescent optics detection system 411.Tool
Body, fluorescent optics detection system 411 includes flow chamber 411a, laser 411b, scattered signal collection device 411c, fluorescence letter
Number collection device 411d, adjusting device of laser device and Control card.
Above-mentioned leukocyte differential count blood sample to be measured enters in flow chamber 411a after being admitted to fluorescent optics detection system 411,
The flow chamber that flowed down is wrapped up in sheath fluid, and inspires fluorescence under the laser that laser 411b is issued and generates scattering light, if
Two optical channels are set, scattered signal is collected by scattered signal collection device 411c in a channel；Another optical channel passes through glimmering
Optical signal collection device 411d collects fluorescence signal.Wherein, scattered signal collection device 411c collect low angle scattered signal, in
Three kinds of angle scattered signal, high angle scatter signal signals can pass through in present embodiment and obtain three kinds of scattered signals and fluorescence letter
Any two or more signal in number is detected, and just carries out five classification to leucocyte by feature difference, to obtain
The testing result that leucocyte five is classified.
It should be pointed out that the antibody in the anti-reagent of A, the anti-reagent of B, the anti-reagent of H, which marks, agent, by anti-
The pairing of original antibody is integrated on the red blood cell in blood sample to be measured.
Further, by taking the blood sample to be measured after A anti-binding as an example, the blood sample to be measured after A anti-binding is being sent into fluorescence light
After the flow chamber 411a for learning detection system 411, art is controlled by fluidic cell, control cell is lined up area after testing one by one, swashs
Light device 411b emits laser to detection zone, so that the fluorescence radiation agent for exciting A to resist issues fluorescence, then passes through fluorescence signal and receives
Acquisition means 411d collects fluorescence information, to obtain the anti-expression intensity of A.Similarly, it can further show that B is anti-respectively and H resists
Expression intensity, and then fluorescent optics detection system 411 can further expression intensity anti-according to obtained A, that B is anti-, H resists obtain
Blood group corresponding to blood sample to be measured.
It should be pointed out that further can show that A is anti-by expression intensity anti-according to A, that B is anti-, H resists in this application scene
The ratio of expression intensity that resists with the ratio of expression intensity that resists of H and the anti-expression intensity and H of B of expression intensity, go forward side by side one
Step obtains sub- blood group corresponding to blood sample to be measured, so that Blood grouping result is more comprehensively, accurately.
In one embodiment, blood sample reaction unit 30 further includes leucocyte/hemoglobin reaction tank 36, blood examination dress
Setting 40 further includes white blood cell count(WBC) detection system 42 and content of hemoglobin detection system 43, leucocyte/hemoglobin reaction tank
36 reception blood sampling units 10 and reagent provide device 20 blood sample and reagent to be measured that provide respectively, with obtain leucocyte/
Hemoglobin blood sample to be measured.
Specifically, obtained leucocyte/hemoglobin blood sample to be measured can be not only used for carrying out leucocyte in present embodiment
Count detection, it can also be used to which content of hemoglobin detects, and in present embodiment, it further includes that hemoglobin is molten that reagent, which provides device 20,
Blood agent provides unit 26, which provides unit 26 for providing hemoglobin hemolytic agent, and the hemoglobin is molten
Blood agent enables to the red blood cell in blood sample to be measured to dissolve, and releases hemoglobin in turn, to detect for white blood cell count(WBC)
And content of hemoglobin detection.
Specifically, while obtaining leukocyte differential count blood sample to be measured and Blood grouping blood sample to be measured, distribution can be passed through
Dilution is provided the dilution in unit 21, blood sample and the hemoglobin haemolysis to be measured in blood sampling unit 10 by system 50
The hemoglobin haemolysis that agent is provided in unit 26 is distributed to the leucocyte/hemoglobin reaction tank 36, and then after hybrid reaction
To leucocyte/hemoglobin blood sample to be measured.
Further, after obtaining leucocyte/hemoglobin blood sample to be measured, white blood cell count(WBC) can be carried out in several ways
Detection and content of hemoglobin detection.It, can be with the side of above-mentioned leukocyte differential count and Blood grouping in an application scenarios
Formula is identical, by distribution system 50 by leucocyte/hemoglobin blood sample to be measured be respectively fed to white blood cell count(WBC) detection system 42 and
Content of hemoglobin detection system 43 obtains white blood cell count(WBC) testing result and content of hemoglobin detection knot to carry out detection
Fruit；In another application scene, carry out white blood cell count(WBC) and content of hemoglobin detection device be directly arranged at leucocyte/
Hemoglobin reaction tank 36, thus with leucocyte/hemoglobin reaction tank 36 collectively form white blood cell count(WBC) detection system 42 and
Content of hemoglobin detection system 43, to can directly be detected after reaction generates leucocyte/hemoglobin blood sample to be measured.
It should be pointed out that present embodiment in, white blood cell count(WBC) detection system 42 can by electrical impedance method to leucocyte/
Total white blood cells in hemoglobin blood sample to be measured are counted, and content of hemoglobin detection system 43 can then pass through colorimetric method pair
Content of hemoglobin in leucocyte/hemoglobin blood sample to be measured is detected.Certainly, it can also adopt in other embodiments
It is detected, is not specifically limited herein in other ways.
In one embodiment, blood sample reaction unit 30 further includes red blood cell/platelet response pond 37, blood examination device
40 further include red blood cell/platelet count detection system 44, red blood cell/platelet response pond 37 receive blood sampling unit 10 and
Reagent provides the blood sample and reagent to be measured that device 20 provides respectively, to obtain red blood cell/blood platelet blood sample to be measured, and further
It is sent into red blood cell/blood platelet blood sample to be measured to red blood cell/platelet count detection system 44, is obtained in terms of red blood cell by carrying out detection
Number testing result and platelet count testing result.
It should be pointed out that the haemocyte in blood is broadly divided into red blood cell, leucocyte and blood platelet, due to leucocyte
Negligible amounts can be ignored for red blood cell and blood platelet, it is therefore not necessary to which special again into blood sample to be measured again add
Enter corresponding leukocytolysis agent to dissolve leucocyte.It specifically, can in acquisition red blood cell/blood platelet blood sample to be measured
To provide dilution to the blood sample to be measured in dilution and blood sampling unit 10 in unit 21 point by distribution system 50
It is assigned to red blood cell/platelet response pond 37 and obtains corresponding red blood cell/blood platelet blood to be measured to be diluted to blood sample to be measured
Sample.
In present embodiment, red blood cell and enumeration of thrombocytes are all made of electrical impedance method progress, and due to red blood cell and blood
The volume difference of platelet is larger, therefore can be detected simultaneously using same detection system.Specifically, using red blood cell/blood
Platelet number detection device and red blood cell/platelet response pond 37 collectively form red blood cell/platelet count detection system 44 simultaneously
Red blood cell and blood platelet are counted simultaneously.
Certainly, in other embodiments, red blood cell/platelet count detection system 44 can also be small with red blood cell/blood
Plate reaction tank 37 is provided separately as two parts, at this point, can be sent into red blood cell/blood platelet blood sample to be measured by distribution system 50
It is counted in red blood cell/platelet count detection system 44.In addition, red blood cell and enumeration of thrombocytes can also exist respectively
It carries out in two different blood examination devices 40, is not specifically limited herein.
In one embodiment, cellanalyzer further includes blood sampling unit cleaning device 60, blood sampling unit
Cleaning device 60 is set to the periphery of blood sampling unit 10, for acquiring blood sample to be measured in blood sampling unit 10, or to blood
After sample reaction unit 30 provides blood sample to be measured, blood sampling unit 10 is cleaned.
It is readily appreciated that ground, acquires blood sample to be measured in blood sampling unit 10, or provide to blood sample reaction unit 30 to be measured
It after blood sample, is easy to leave bloodstain in the exit of blood sample to be measured, in order to avoid cross-infection, can be executed every time in blood sample to be measured
It is cleaned by blood sampling unit cleaning device 60 after stating movement, to keep cleaning.
Specifically, blood sampling unit cleaning device 60 may be provided with entrance and exit, and cleaning solution is from entrance into from outlet
Out, it is discharged outside instrument by waste liquid discharge device 60, to complete the cleaning to blood sampling unit 10 in this course.
In an application scenarios, dilution further can be provided to the dilution in unit 21 by distribution system 50 and distributed to blood sample
Acquisition device cleaning device 60, and blood sampling unit 10 is cleaned using dilution as cleaning solution.
In present embodiment, blood sampling unit 10 can be sampling needle.
In addition, in the process for carrying out above-mentioned every detection, and after the completion of detection, it is also necessary to blood sample reaction unit
30 and detection system cleaned.In one embodiment, the blood sample to be measured after reacting in each blood sample reaction unit 30 is sent
After entering corresponding blood examination device 40, dilution can be provided to a certain amount of dilution in unit 21 by distribution system 50
Liquid is distributed to the blood sample reaction unit 30 and is cleaned.It should be pointed out that leukocyte differential count/blood group in above embodiment
35 time-sharing multiplex of reaction tank is detected, it is to be measured after using the leukocyte differential count/Blood grouping reaction tank 35 to be reacted every time
It is required to clean it after blood sample, to keep cleaning.Similarly, after blood examination device 40 detects, it is also desirable to
Dilution is provided to a certain amount of dilution in unit 21 by distribution system 50 to distribute to the blood examination device 40 to it
It is cleaned.
Further, in one embodiment, cellanalyzer further includes waste liquid discharge device 70, for blood sample to be discharged
Waste liquid caused by reaction unit 30, blood examination device 40 and blood sampling unit cleaning device 60.
Be readily appreciated that ground, to above-mentioned blood sample reaction unit 30, blood examination device 40 and blood sampling unit 10 into
When row cleaning, certain waste liquid can be generated, blood sample reaction unit 30, blood examination device 40 and blood sample are adopted in present embodiment
Acquisition means cleaning device 60 is further connected with waste liquid discharge device 70, so that generated discharging of waste liquid to the waste liquid be arranged
It puts in device 70, and is further expelled to the outside of cellanalyzer.
The foregoing is merely presently filed embodiments, are not intended to limit the scope of the patents of the application, all to utilize this
Equivalent structure or equivalent flow shift made by application specification and accompanying drawing content, it is relevant to be applied directly or indirectly in other
Technical field similarly includes in the scope of patent protection of the application.
Claims (10)
1. a kind of cellanalyzer, which is characterized in that the cellanalyzer includes:
Blood sampling unit, for acquiring and providing blood sample to be measured；
Reagent provides device, analyzes reagent used in the blood sample to be measured for providing；
Blood sample reaction unit is mentioned for receiving the blood sample to be measured and the reagent provided by the blood sampling unit
It is anti-to respectively obtain blood sample and H to be measured after the blood sample to be measured after A anti-binding, B anti-binding for the reagent provided by device
Blood sample to be measured in conjunction with after；
Blood examination device, the blood examination device include fluorescent optics detection system, and the fluorescent optics detection system is used
After receiving the blood sample to be measured after the A anti-binding, the blood sample to be measured after the B anti-binding and the H anti-binding respectively to
Blood sample is surveyed, Blood grouping is carried out, to show that A type blood testing result, Type B blood testing result, O-shaped blood examination are surveyed as a result, in turn respectively
Obtain the Blood grouping result of the blood sample to be measured.
2. cellanalyzer according to claim 1, which is characterized in that the cellanalyzer further includes distribution system
System；
The distribution system is used for will be in the blood sample to be measured and reagent offer device in the blood sampling unit
The reagent be respectively allocated to the blood sample reaction unit, and by the blood to be measured after the reaction in the blood sample reaction unit
Sample is distributed to the fluorescent optics detection system.
3. cellanalyzer according to claim 2, which is characterized in that the blood sample reaction unit includes leucocyte point
The anti-reaction tank of class reaction tank, A, the anti-reaction tank of B and the anti-reaction tank of H；
Wherein, by the distribution system by the blood sampling unit the blood sample to be measured and the reagent device is provided
In the reagent distribute to the leukocyte differential count reaction tank, the anti-reaction tank of the A, the anti-reaction tank of the B and the H anti-reflective
Ying Chi, to obtain the blood sample to be measured after leukocyte differential count blood sample to be measured, the A anti-binding, the blood to be measured after the B anti-binding
Blood sample to be measured after sample, the H anti-binding, and further by the distribution system by leukocyte differential count blood sample to be measured,
The blood sample to be measured after blood sample to be measured, the B anti-binding after the A anti-binding, the blood sample timesharing to be measured after the H anti-binding point
It is assigned to the leukocyte differential count/Blood grouping system to be detected, to show that leukocyte differential count testing result, A type blood examination survey knot
Fruit, Type B blood testing result, O-shaped blood testing result.
4. cellanalyzer according to claim 2, which is characterized in that the blood sample reaction unit includes leucocyte point
Class/Blood grouping reaction tank；
Wherein, the leukocyte differential count/Blood grouping reaction tank time-sharing multiplex, by the distribution system by the blood specimen collection
The blood sample to be measured and the reagent in device provide the reagent in device and distribute to the leukocyte differential count/blood group inspection
It surveys in reaction tank, the blood sample to be measured after leukocyte differential count blood sample to be measured, A anti-binding are obtained with timesharing, the blood to be measured after B anti-binding
Blood sample to be measured after sample, H anti-binding, and further by the distribution system by leukocyte differential count blood sample to be measured, the A
The blood sample to be measured after blood sample to be measured, the B anti-binding after anti-binding, the blood sample timesharing to be measured after the H anti-binding distribute to
The leukocyte differential count/Blood grouping system is detected, to obtain leukocyte differential count testing result, A type blood testing result, B
Type blood testing result, O-shaped blood testing result.
5. cellanalyzer according to claim 3 or 4, which is characterized in that the fluorescent optics detection system includes
Flow chamber, laser, fluorescence signal reception device；
The blood sample to be measured after blood sample to be measured, the B anti-binding after the A anti-binding, the blood sample to be measured after the H anti-binding point
The flow chamber is not flowed through, and the detection zone of flow chamber described in the laser transmitting laser irradiation generates fluorescence signal, described glimmering
Light signal receiving receives the fluorescence signal and obtains respectively, A type blood testing result, Type B blood testing result, O-shaped blood examination
Survey result.
6. cellanalyzer according to claim 2, which is characterized in that the blood sample reaction unit further includes white thin
Born of the same parents/hemoglobin reaction tank, the blood examination device further include white blood cell count(WBC) detection system and content of hemoglobin detection
System；
The distribution system is by the blood sample to be measured in the blood sampling unit and described in the reagent provides in device
Reagent is distributed to the leucocyte/hemoglobin reaction tank, to obtain leucocyte/hemoglobin blood sample to be measured, the leucocyte
Counting detection system and the content of hemoglobin detection system receive leucocyte/hemoglobin blood sample to be measured, with respectively
It carries out detection and obtains white blood cell count(WBC) testing result and content of hemoglobin testing result.
7. cellanalyzer according to claim 2, which is characterized in that the blood sample reaction unit further includes red thin
Born of the same parents/platelet response pond, the blood examination device further include red blood cell/platelet count detection system；
The distribution system is by the blood sample to be measured in the blood sampling unit and described in the reagent provides in device
Reagent is distributed to the red blood cell/platelet response pond, and to obtain red blood cell/blood platelet blood sample to be measured, the red blood cell/blood is small
Plate counting detection system receives red blood cell/blood platelet blood sample to be measured, obtains red blood cell count(RBC) testing result to carry out detection
And platelet count testing result.
8. cellanalyzer according to claim 1, which is characterized in that it includes that dilution mentions that the reagent, which provides device,
Unit is provided for unit, leukocyte classification hemolytic agent, hemoglobin hemolytic agent provides the anti-reagent of unit, A and provides unit, the anti-examination of B
Agent provides the anti-reagent of unit, H and provides unit；
Wherein, the dilution provides unit and provides unit for mentioning for providing dilution, the leukocyte classification hemolytic agent
For leukocyte classification hemolytic agent, the hemoglobin hemolytic agent provides unit for providing hemoglobin hemolytic agent, the anti-examination of A
Agent provides unit and provides unit for providing the anti-reagent of A, the anti-reagent of B and provide for providing the anti-reagent of B, the anti-reagent of H
Unit is for providing the anti-reagent of H.
9. cellanalyzer according to claim 1, which is characterized in that the cellanalyzer further includes that blood sample is adopted
Acquisition means cleaning device, the blood sampling unit cleaning device are set to the periphery of the blood sampling unit, in institute
It states blood sampling unit and acquires the blood sample to be measured, or after providing the blood sample to be measured to the blood sample reaction unit, to described
Blood sampling unit is cleaned.
10. cellanalyzer according to claim 9, which is characterized in that the cellanalyzer further includes waste liquid
Tapping equipment, for the blood sample reaction unit, the blood examination device and the blood sampling unit cleaning device to be discharged
Generated waste liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201821622446.8U CN209416919U (en) | 2018-09-30 | 2018-09-30 | Cellanalyzer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201821622446.8U CN209416919U (en) | 2018-09-30 | 2018-09-30 | Cellanalyzer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN209416919U true CN209416919U (en) | 2019-09-20 |
Family
ID=67931421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201821622446.8U Active CN209416919U (en) | 2018-09-30 | 2018-09-30 | Cellanalyzer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN209416919U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114062036A (en) * | 2020-07-31 | 2022-02-18 | 深圳市帝迈生物技术有限公司 | Blood sample distribution method, blood detection device, and computer-readable storage medium |
-
2018
- 2018-09-30 CN CN201821622446.8U patent/CN209416919U/en active Active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114062036A (en) * | 2020-07-31 | 2022-02-18 | 深圳市帝迈生物技术有限公司 | Blood sample distribution method, blood detection device, and computer-readable storage medium |
| CN114062036B (en) * | 2020-07-31 | 2023-12-29 | 深圳市帝迈生物技术有限公司 | Blood sample distribution method, blood detection device, and computer-readable storage medium |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11959911B2 (en) | Blood analysis method, control device and blood cell analyzer | |
| US20230294089A1 (en) | Automated microscopic cell analysis | |
| CN102016573B (en) | Blood analyzer, blood analysis method, hemolytic agent and staining agent | |
| CN105807038B (en) | Cellanalyzer, method for analyzing body fluid and its control system | |
| CN102016577B (en) | Blood analyzer, blood analysis method and hemolytic agent | |
| CN102300641B (en) | Microfluidic device for full blood count | |
| CN103278654B (en) | Sample analyzer and control system thereof | |
| CN105051538B (en) | For detecting the system and method for biological condition | |
| CN105699635A (en) | Simple and reliable hemocyte five-class analysis method, system and device | |
| CN106018771B (en) | Blood analysis device and blood analysis method | |
| US20120214224A1 (en) | Flow based clinical analysis | |
| CN103941026A (en) | Sample analyzer | |
| CN205538976U (en) | Simple reliable five categorised analytical equipment of blood cell | |
| CN107037200B (en) | Specimen inspection system, information processing unit and information processing method | |
| CN110068697A (en) | Device for analyzing samples | |
| CN108663304A (en) | Reagent selects assisting system, method, program, storage media and measurement device | |
| CN107525758A (en) | Blood analyser is controlled to determine hematoblastic method | |
| CN104251901B (en) | Device for analyzing samples and analysis system and abnormal detector and detection method | |
| CN209416919U (en) | Cellanalyzer | |
| KR101628578B1 (en) | Blood cell analysis apparatus | |
| CN105973811A (en) | Analyzer with blood analysis and biochemical analysis functions, and method thereof | |
| CN110967322A (en) | Blood cell analyzer and blood cell analyzing method | |
| CN207366563U (en) | A kind of classification of compatible leucocyte five and leucocyte three divide the cellanalyzer of group | |
| US6867049B1 (en) | Method for obtaining increased particle concentration for optical examination | |
| CN210005546U (en) | Blood detection device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20200528 Granted publication date: 20190920 |
|
| PP01 | Preservation of patent right | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20220919 Granted publication date: 20190920 |
|
| PD01 | Discharge of preservation of patent |